Group One Trading’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Group One Trading’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,600	Closed	-$46K	–	5157
2016 Q2	$46K	Buy	+6,600	New	+$46.5K	﹤0.01%	3359
2016 Q1	–	Sell	-800	Closed	-$8K	–	5264
2015 Q4	$8K	Sell	800 -7,200	-90%	-$83.5K	﹤0.01%	4273
2015 Q3	$94K	Buy	+8,000	New	+$88.4K	﹤0.01%	3089
2014 Q4	–	Sell	-22,400	Closed	-$132K	–	5538
2014 Q3	$132K	Sell	22,400 -29,600	-57%	-$181K	﹤0.01%	2755
2014 Q2	$356K	Buy	52,000 +16,300	+46%	+$109K	0.01%	1927
2014 Q1	$258K	Buy	35,700 +27,400	+330%	+$189K	﹤0.01%	2224
2013 Q4	$55K	Buy	+8,300	New	+$56.5K	﹤0.01%	3542

Group One Trading's JNP Position: Q3 2016 in Review

Group One Trading sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2016, closing a stake of 6,597 shares — an estimated $43.6K sold.

Group One Trading first reported a position in JNP in Q1 2014 and held it in 7 quarters. The position peaked at $129K in Q1 2016. 46 funds tracked by Wall St. Rank hold JNP as of Q3 2016.

Group One Trading reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Group One Trading sold 6,597 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2016, an estimated $43.6K.
Group One Trading first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2014 and held it in 7 quarters.
Group One Trading's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $129K in Q1 2016.
46 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2016.

Based on Group One Trading's 13F filing for Q3 2016, filed 14 Nov 2016.